SPEAKERS

LOCATIONSCIENTIFIC CHAIRMEN:

ORGANIZING SECRETARIAT & CME PROVIDER

SPONSORED BY

CREMONAPALAZZO TRECCHI - Via S. Trecchi, 20 ALBERTO BOTTINI

BREAST UNIT OSPEDALE DI CREMONA

HONORARY PRESIDENT

Prof. LUIGI DOGLIOTTIFRANCESCO LANZAREPARTO EMATOLOGIA OSPEDALE DI CREMONA

Alfredo Berruti – Brescia Giuliana Bodini – CremonaAttilio Bondanza – Milano Alberto Bottini – Cremona Marco Bregni – Milano Riccardo Caccialanza – Pavia Ettore Capoluongo – Roma Patrizia Comoli – Pavia Giovanni Corrao – Milano Giuseppe Curigliano – Milano Clifford Alan Hudis – New York Mariagrazia Daidone – Milano Andrea De Censi – Genova Martina Dester – Cremona Luigi Dogliotti – Cremona Giuseppina Ferrero – Cremona Alessandra Gennari – Genova Donatella Gramaglia – RomaFrancesco Lanza – Cremona Andrea Machiavelli – Cremona Mario Melazzini – Milano Enrica Morra – Milano Manuela Milani – Cremona Andrea Necchi – Milano Rodolfo Passalacqua – CremonaPaolo Pedrazzoli – Pavia Bruno Perrucci – Cremona Paolo Radice – Milano James Reuben – Houston Camillo Rossi – Cremona Giovanni Rosti – TrevisoFrancesco Scaglione – Milano Daniele Spada – Cremona Carla Strina – Cremona Tullio Testa – CremaCorrado Tinterri – Rozzano

WITH THE PARTNERSHIP OF

IT WAS REQUESTED PATRONAGE TO- Regione Lombardia- Società Italiana di Senologia (SIS)- Associazione Italiana di Oncologia Medica (AIOM)- Società Italiana di Farmacia Ospedaliera (SIFO)- EXPO Milano 2015

IT WAS GRANTED THE PATRONAGE OF

OVER SRLvia Pagliari, 4 - 26100 Cremonatel 0372 23310 fax 0372 569605info@overgroup.eu www.overgroup.eu

EBMT STWP

AUTUMN MEETING

A MULTISPECIALIST

PATHWAY TOWARDS

A THERAPY AND

HEALTH-EDUCATION

MODEL

SEPTEMBER 30 –

OCTOBER 1, 2015

CREMONA

PALAZZO TRECCHI

EBMT STWP AUTUMN MEETINGA MULTISPECIALIST PATHWAY TOWARDS A THERAPY AND HEALTH-EDUCATION MODEL

SEPTEMBER 30 – OCTOBER 1, 2015

CREMONAPALAZZO TRECCHI - Via S. Trecchi, 20

JUST PHARMA

Wednesday

Registration

Greeting to AuthoritiesREGIONE LOMBARDIA HEALTH ASSESSORMARIO MANTOVANIAO CREMONA GENERAL DIRECTORSIMONA MARIANIDIPO DIRECTORINES CAFAROASL CREMONA GENERAL DIRECTORGILBERTO COMPAGNONI

WORKSHOPEBMT- Solid Tumor Working Party (STWP) MODERATORS: E. MORRA, F. LANZA

Perspectives of cell therapy in solid tumors; P. COMOLI

A reappraisal of cell and gene therapy in the EU: the EBMT perspectiveA. BONDANZA

Which funding (support) for cell therapy studies in malignancies? AIFA point of viewD. GRAMAGLIA

COFFEE BREAK

MODERATORS: M. BREGNI, G. ROSTI

Breast cancer: prospective and retrospective studiesP. PEDRAZZOLI

GCT: prospective and retrospective studiesA. NECCHI

Biological studies in the setting of transplantation J. M. REUBEN

THE MULTISPECIALIST PATHWAY: THERAPY AND HEALTH EDUCATION

MASTERLY READINGThe Value of Cancer Care: from the Society to the ScienceC. A. HUDIS

LUNCH

09.45

10.15

10.30

10.50

11.20

11.45

12.00

12.15

12.30

Health, intended as physical, mental and social well-being, has to be considered as a daily life resource and, because it involves population's living context, it is increasingly becoming a collective responsability. Health promotion is an educational process which tends to render individuals – both singles and groups – feel more responsible in the defence of self and other people's health. Daily life becomes then the privileged space for health promotion, being this last a process which cannot be just considered as the result of a single action or intervention, but it better has to be seen as a com-plex process implying several the responsability of several actors.

With the aim of responding to these increasingly complex needs, the field of oncology is being organized into network models, mainly on a regio-nal scheme.

The network is a tool which must be adapted to the territory in which it acts according to people's experiences and skills, and which is not able to develop if not adequately supported by institutions.

The multidisciplinary-integrated approach built by/on professionists and sustained by institutions today represents the best guarantee of the quality and efficiency of the diagnostic, therapeutic and supportive pathway for patients affected by solid and liquid neoplasms. Such approach allows today to set up a personalized treatment according to disease characteristics, patient's desire and patient's overall health conditions, promoting meantime a proper health educative process for patients them-selves and for caregivers.

PROGRAMRATIONALE

14.1516.15

15.30

15.55

16.15

16.35

16.55

17.35

18.00

09.00

09.20

STWP BUSINESS MEETING (agenda to be sent to EBMT members before the meeting) 1. STWP registry report; 2. Ongoing retrospective studies; 3. Ongoing prospective studies; 4. New proposals.

The way of taste: at lunch with science through the genomic pathway in CremonaM. DESTER

COFFEE BREAK

MODERATORS: G. BODINI, L. DOGLIOTTI DISCUSSANT: A. BOTTINI

Oncologic pathologies and lifestylesA. GENNARI

Nutrigenomics tests responses, clinical implicationsR. CACCIALANZA

Prevention in tumours: the use of natural substances or of vegetable originA. DE CENSI

Discussion

EXPO 2015: from feeding the planet to energy for researchM. MELAZZINI

Opening to Apericena LA SALUTE IN TAVOLA (“HEALTH ON THE TABLE / AT LUNCH WITH HEALTH”)W. BERGAMASCHI INTERVENTIONLOMBARDIA REGION HEALTH GENERAL DIRECTOR

Thursday

MODERATORS: G. CORRAO, C. ROSSI DISCUSSANT: R. PASSALACQUA

Technological innovation, economic dimension, organizational dimension: the role of the department pharmacistA. MACHIAVELLIInnovation in oncology in support to experimenta-tion and clinical routine

09.40

10.00

10.20

10.40

11.00

11.20

11.40

12.00

12.20

12.40

13.00

13.20

13.30

G. CURIGLIANO

Personalized medicine and novel target molecules in oncologyB. PERRUCCI

Knowledge of the molecular basis of inherited susceptibility to cancer: opportunities and challengesP. RADICE

Liquid biopsy and innovative therapeutic strategiesMG. DAIDONE

Discussion

Coffee Break

MODERATORS: G. FERRERO, T. TESTA DISCUSSANT: A. BERRUTI

Diagnostic highlights for novel molecules in female tumoursE. CAPOLUNGO

Oncologic highlights: HER2-, HER2+, triple-negative breast cancerM. MILANI

Highlights in bone-metastases therapy and tumour microenvironment; D. SPADA

Highlights in breast surgery; C. TINTERRI

Novel molecules in breast tumoursC. STRINA

Polymorphisms: therapeutic choice driversF. SCAGLIONE

Discussion

Closure Lunch